Modal Title

Modal Title

  • English
    • Deutsch
  • X

Page Title


Primary tumor thickness cannot be assessed, e.g., in cases of curettaged primary tumor.

No information

No information


No evidence of primary tumor, e.g., in occult melanoma or completely regressed primary tumor.

No information

No information


(Melanoma In-situ)

No information

No information


 

≤1,0 mm

Unknown or not specified


 

< 0,8 mm

Without ulceration


 

< 0,8 mm / 
0,8  mm – 1,0 mm

With ulceration / With/Without ulceration


 

>1.0–2.0 mm

Unknown or not specified


 

>1.0–2.0 mm

Without ulceration


 

>1.0–2.0 mm

With ulceration


 

>2.0‐4.0 mm

Unknown or not specified


 

>2.0‐4.0 mm

Without ulceration


 

>2.0‐4.0 mm

With ulceration


 

>4.0 mm

Unknown or not specified


 

>4.0 mm

Without ulceration


 

>4.0 mm

With ulceration



 

A clinically 'occult' metastatically involved lymph node (e.g., diagnosed using sentinel lymph node biopsy).

No


 

No regional lymph node metastasis

No


 

A metastatically involved lymph node OR in transit, satellite, and/or microsatellite metastases WITHOUT a metastatically involved lymph node.

 


 

A clinically 'occult' metastatically involved lymph node (e.g., diagnosed using sentinel lymph node biopsy).

No


 

A clinically metastatically involved lymph node.

No


 

No regional metastatically involved lymph node.

Yes


 

Two or three metastatically involved lymph nodes OR in transit, satellite, and/or microsatellite metastases with one metastatically involved lymph node.

 


 

Two or three clinically 'occult' metastatically involved lymph nodes (e.g., diagnosed using sentinel lymph node biopsy).

No


 

Two or three metastatically involved lymph nodes, with at least one lymph node clinically diagnosed.

No


 

One metastatically involved lymph node ('occult' or clinically diagnosed).

Yes


 

Four or more metastatic lymph nodes OR intransit, satellite and/or microsatellite metastases with two or more metastatic lymph nodes OR ā€œclusteredā€ lymph node conglomerate WITHOUT intransit, satellite and/or microsatellite metastases

 


 

Four or more metastatic lymph nodes in which at least one lymph node has been clinically diagnosed.

No


 

Four or more metastatic lymph nodes in which at least one lymph node has been clinically diagnosed.

No


 

Two or more ā€œoccultā€ or clinically metastatic lymph nodes and/or ā€œclusteredā€ lymph node conglomerate

Yes



 

No distant metastasis.

 


 

Presence of distant metastasis.

 


 

Distant metastases, particularly in the skin, soft tissues including muscles, and/or non-regional lymph nodes.

Normal


 

Distant metastases, particularly in the skin, soft tissues including muscles, and/or non-regional lymph nodes.

Normal


 

Distant metastases, particularly in the skin, soft tissues including muscles, and/or non-regional lymph nodes.

Increased


 

Distant metastases, particularly in the lungs; with or without involvement of the sites coded under M1a.

Not determined or not documented.


 

Distant metastases, particularly in the lungs; with or without involvement of the sites coded under M1a.

Normal


 

Distant metastases, particularly in the lungs; with or without involvement of the sites coded under M1a.

Increased


 

Distant metastases, particularly in other visceral sites WITHOUT CNS involvement; with or without involvement of the sites coded under M1a or M1b.

Not determined or not document


 

Distant metastases, particularly in other visceral sites WITHOUT CNS involvement; with or without involvement of the sites coded under M1a or M1b.

Normal


 

Distant metastases, particularly in other visceral sites WITHOUT CNS involvement; with or without involvement of the sites coded under M1a or M1b.

Increased


 

Distant metastases, particularly in the CNS; with or without involvement of the sites coded under M1a, M1b, or M1c.

Not determined or not documented.


 

Distant metastases, particularly in the CNS; with or without involvement of the sites coded under M1a, M1b, or M1c.

Normal


 

Distant metastases, particularly in the CNS; with or without involvement of the sites coded under M1a, M1b, or M1c.

Increased